BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Sarepta (SRPT) Announces Plans To Submit Rolling NDA For Eteplirsen Following Today’s Pre-NDA Meeting With The FDA 5/20/2015 6:02:25 AM
Wall Street Cheers As Sarepta (SRPT) Soars 50% Premarket on Muscular Dystrophy Drug Filing 5/20/2015 6:01:00 AM
Sarepta (SRPT) Announces First Quarter 2015 Financial Results And Recent Corporate Developments 5/7/2015 12:50:06 PM
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/1/2015 10:14:15 AM
Sarepta (SRPT) To Announce First Quarter 2015 Financial Results And Recent Corporate Developments On May 7, 2015 4/30/2015 12:45:42 PM
Q&A With Former CEO Of Sarepta (SRPT) 4/29/2015 7:23:32 AM
Interview With Sarepta (SRPT)'s New CEO 4/3/2015 7:26:12 AM
Wall Street Cheers As Sarepta (SRPT) CEO is Ousted, Analysts Say 4/2/2015 9:09:24 AM
Sarepta (SRPT) Appoints Edward Kaye, M.D., As Interim CEO; Company On Track With Clinical And Regulatory Plans For Investigational Duchenne Muscular Dystrophy Drugs 4/1/2015 7:08:57 AM
Sarepta (SRPT) CEO Resigns Abruptly, Was "In Over His Head" 4/1/2015 7:07:09 AM
12345678910...